智慧护理输液系统在生长激素腺瘤合并心肌病患者输液管理中的应用

Effects of intelligent nursing and transfusion system on transfusion management in patients with growth hormone adenoma complicated with cardiomyopathy

目的评价智慧护理输液系统在生长激素腺瘤合并心肌病患者输液管理中的应用效果.方法选取2018年1月—2019年5月北京某三级医院神经外科收治的生长激素腺瘤合并心肌病患者作为研究对象.其中2018年1—10月采用常规输液管理的78例患者为对照组;2018年11月—2019年5月应用智慧护理输液管控系统后住院的70例患者为试验组.评价两组患者输液过程中不良反应发生率、输液速度正确率、心律失常发生率和患者因输液问题投诉率.结果试验组输液不良反应发生率为5.7%,低于对照组的16.7%;输液速度准确率为97.0%,高于对照组的89.3%;差异有统计学意义(P<0.05).试验组和对照组心律失常发生率分别为3.6%和6.7%,差异无统计学意义(P>0.05).试验组因输液问题发生的投诉率为5.7%,低于对照组的16.7%,差异有统计学意义(P<0.05).结论智慧护理输液系统的应用可改善临床输液管理,不仅可以降低输液不良反应发生率,提高生长激素腺瘤合并心肌病患者的输液安全性,还可降低患者因输液问题的投诉率,提升患者满意度.

Objective To evaluate the effects of the intelligent nursing and transfusion system on transfusion management in patients with growth hormone adenoma complicated with cardiomyopathy.Methods The patients with growth hormone adenoma complicated with cardiomyopathy treated in the Department of Neurosurgery in a Class Ⅲ Grade A hospital from January 2018 to May 2019 were selected.Totally 78 patients receiving conventional transfusion management from January to October 2018 were included into the control group,while 70 patients admitted from November 2018 to May 2019 after the intelligent nursing and transfusion system was applied were included into the experimental group.The incidence rate of adverse effects in transfusion,correct rate of transfusion speed,incidence rate of arrhythmia and patients,compliant rate in terms of transfusion were evaluated between the two groups.Results The incidence rate of adverse effects in transfusion in the experimental group was 5.7%,lower than 16.7% in the control group.The correct rate of transfusion speed was 97.0% in the experimental group,higher than 89.3% in the control group,and there was statistically significant difference between the two groups(P<0.05).The incidence rates of arrhythmia in the experimental and control groups were 3.6%and 6.7%,respectively,and there was no statistically significant difference between the two groups(P>0.05).The compliant rate about transfusion was 5.7%in the experimental group,lower than 16.7% in the control group,and there was statistically significant difference between the two groups(P <0.05).Conclusions The intelligent nursing and transfusion system can improve transfusion management in clinical practice,which not only reduce the incidence rate of adverse effects in transfusion and improve the transfusion safety in patients with growth hormone adenoma romplirated with cardiomyopathy,and also reduce the compliant rate about transfusion and improve patientsf satisfaction.